Celebrating 10 Years of Public Health System Strengthening in Zambia

By Lucy Slater, Director, Global Program

Like all organizations, NASTAD Global goes through cycles – cycles of staffing, cycles of scopes of work, and cycles of funding. In 2015, we approach a convergence of these cycles, and as some new opportunities are emerging, we are also finding that some existing work must end. As of March 31, 2015, the outcomes of NASTAD Global’s HIV health systems strengthening assistance for national government partners in Zambia will have been integrated into government structures and we will close the doors to our Zambia office.

Continue reading

Raising the Bars: Addressing the Deterrent Effects of HIV-related Stigma and Discrimination

By Lucy Slater, Director, Global Program, NASTAD

RTB Post #8 GraphicNASTAD’s Global Program builds the organizational, programmatic and human resource capacity of regional/state public sector HIV program counterparts around the world.

The HIV Care Continuum can help to identify needs and measure progress toward stronger outcomes in achieving an AIDS-free generation. NASTAD’s Global Program works with peer public health agencies in countries around the world to strengthen the HIV Care Continuum by providing targeted training, technical assistance and supportive supervision. The previous blog posts describing how we are “Raising the Bars” can be found below: Continue reading

NASTAD Helps Strengthen Zambia’s National HIV/AIDS Strategic Framework

By Maybin Mumba, Monitoring and Evaluation Program Manager, NASTAD Zambia, and Anna Carroll, Associate, Global Program, NASTAD

Zambia has one of the most severe HIV epidemics in the world, with an estimated adult prevalence of 12.7%. Over one million people are living with HIV in Zambia today. Despite these stark figures, the country has made significant progress in combating the disease. The national adult prevalence has decreased steadily since 2000, from 15.3% to the current 12.7%, and significant strides have been made in the prevention of new infections and the provision of anti-retroviral therapies. Continue reading